Invesco’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1B | Buy |
2,235,720
+72,459
| +3% | +$39.3M | 0.11% | 155 |
|
|
2025
Q4 | $1.25B | Buy |
2,163,261
+247,975
| +13% | +$140M | 0.12% | 142 |
|
|
2025
Q3 | $929M | Buy |
1,915,286
+355,659
| +23% | +$166M | 0.15% | 136 |
|
|
2025
Q2 | $632M | Sell |
1,559,627
-128,587
| -8% | -$53.8M | 0.11% | 220 |
|
|
2025
Q1 | $840M | Buy |
1,688,214
+10,633
| +0.6% | +$5.76M | 0.16% | 135 |
|
|
2024
Q4 | $873M | Buy |
1,677,581
+99,688
| +6% | +$54.8M | 0.16% | 120 |
|
|
2024
Q3 | $976M | Buy |
1,577,893
+101,345
| +7% | +$60M | 0.19% | 100 |
|
|
2024
Q2 | $817M | Buy |
1,476,548
+144,348
| +11% | +$82.7M | 0.17% | 111 |
|
|
2024
Q1 | $774M | Sell |
1,332,200
-341,743
| -20% | -$192M | 0.17% | 123 |
|
|
2023
Q4 | $889M | Sell |
1,673,943
-23,845
| -1% | -$11.5M | 0.21% | 87 |
|
|
2023
Q3 | $859M | Buy |
1,697,788
+142,850
| +9% | +$76.1M | 0.23% | 72 |
|
|
2023
Q2 | $811M | Sell |
1,554,938
-402,425
| -21% | -$217M | 0.21% | 90 |
|
|
2023
Q1 | $1.13B | Buy |
1,957,363
+57,335
| +3% | +$32.3M | 0.31% | 44 |
|
|
2022
Q4 | $1.05B | Buy |
1,900,028
+110,309
| +6% | +$58.5M | 0.31% | 49 |
|
|
2022
Q3 | $908M | Buy |
1,789,719
+193,528
| +12% | +$108M | 0.29% | 50 |
|
|
2022
Q2 | $867M | Buy |
1,596,191
+96,289
| +6% | +$53M | 0.26% | 63 |
|
|
2022
Q1 | $886M | Buy |
1,499,902
+32,582
| +2% | +$18.7M | 0.23% | 76 |
|
|
2021
Q4 | $979M | Buy |
1,467,320
+185,998
| +15% | +$116M | 0.24% | 73 |
|
|
2021
Q3 | $732M | Sell |
1,281,322
-160,827
| -11% | -$88.3M | 0.19% | 110 |
|
|
2021
Q2 | $728M | Sell |
1,442,149
-907,787
| -39% | -$428M | 0.18% | 115 |
|
|
2021
Q1 | $1.07B | Sell |
2,349,936
-108,242
| -4% | -$51.7M | 0.29% | 49 |
|
|
2020
Q4 | $1.14B | Sell |
2,458,178
-142,491
| -5% | -$66.8M | 0.33% | 35 |
|
|
2020
Q3 | $1.15B | Sell |
2,600,669
-91,793
| -3% | -$37.9M | 0.39% | 33 |
|
|
2020
Q2 | $976M | Buy |
2,692,462
+46,676
| +2% | +$15.6M | 0.35% | 41 |
|
|
2020
Q1 | $750M | Buy |
2,645,786
+98,418
| +4% | +$31M | 0.32% | 56 |
|
|
2019
Q4 | $828M | Sell |
2,547,368
-148,097
| -5% | -$44.9M | 0.26% | 73 |
|
|
2019
Q3 | $785M | Buy |
2,695,465
+561,839
| +26% | +$161M | 0.21% | 96 |
|
|
2019
Q2 | $627M | Sell |
2,133,626
-4,900
| -0.2% | -$1.35M | 0.16% | 130 |
|
|
2019
Q1 | $585M | Sell |
2,138,526
-189,008
| -8% | -$47M | 0.2% | 109 |
|
|
2018
Q4 | $521M | Buy |
2,327,534
+191,103
| +9% | +$44.8M | 0.2% | 110 |
|
|
2018
Q3 | $521M | Sell |
2,136,431
-31,722
| -1% | -$7.3M | 0.16% | 140 |
|
|
2018
Q2 | $449M | Buy |
2,168,153
+306,515
| +16% | +$65.1M | 0.15% | 150 |
|
|
2018
Q1 | $384M | Buy |
1,861,638
+23,165
| +1% | +$4.86M | 0.14% | 161 |
|
|
2017
Q4 | $349M | Buy |
1,838,473
+38,682
| +2% | +$7.41M | 0.13% | 195 |
|
|
2017
Q3 | $341M | Sell |
1,799,791
-114,600
| -6% | -$20.8M | 0.13% | 200 |
|
|
2017
Q2 | $334M | Sell |
1,914,391
-123,779
| -6% | -$20.8M | 0.1% | 216 |
|
|
2017
Q1 | $313M | Sell |
2,038,170
-498,058
| -20% | -$76.1M | 0.1% | 225 |
|
|
2016
Q4 | $358M | Sell |
2,536,228
-325,186
| -11% | -$47.9M | 0.12% | 185 |
|
|
2016
Q3 | $455M | Sell |
2,861,414
-193,072
| -6% | -$29.8M | 0.16% | 140 |
|
|
2016
Q2 | $451M | Sell |
3,054,486
-124,506
| -4% | -$18.4M | 0.17% | 136 |
|
|
2016
Q1 | $450M | Buy |
3,178,992
+994,226
| +46% | +$133M | 0.18% | 121 |
|
|
2015
Q4 | $310M | Buy |
2,184,766
+377,008
| +21% | +$50.3M | 0.12% | 187 |
|
|
2015
Q3 | $221M | Buy |
1,807,758
+30,291
| +2% | +$3.95M | 0.09% | 249 |
|
|
2015
Q2 | $231M | Sell |
1,777,467
-645,532
| -27% | -$84.2M | 0.09% | 268 |
|
|
2015
Q1 | $326M | Sell |
2,422,999
-348,076
| -13% | -$44.9M | 0.13% | 196 |
|
|
2014
Q4 | $347M | Buy |
2,771,075
+27,789
| +1% | +$3.38M | 0.13% | 176 |
|
|
2014
Q3 | $334M | Sell |
2,743,286
-126,641
| -4% | -$15.4M | 0.13% | 182 |
|
|
2014
Q2 | $339M | Buy |
2,869,927
+355,486
| +14% | +$41.8M | 0.13% | 180 |
|
|
2014
Q1 | $302M | Buy |
2,514,441
+64,849
| +3% | +$7.71M | 0.12% | 195 |
|
|
2013
Q4 | $273M | Sell |
2,449,592
-40,049
| -2% | -$3.98M | 0.11% | 215 |
|
|
2013
Q3 | $229M | Buy |
2,489,641
+15,451
| +0.6% | +$1.4M | 0.1% | 237 |
|
|
2013
Q2 | $209M | Buy |
+2,474,190
| New | +$206M | 0.1% | 241 |
|
Other funds holding TMO
VCM
Invesco's TMO Position: Q1 2026 in Review
Invesco increased its Thermo Fisher Scientific (TMO) stake by 3.3% in Q1 2026, buying an estimated $39.3M and bringing the position to 2,235,720 shares worth $1.1B. The position accounts for 0.11% of the portfolio, ranked #155.
Invesco first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.25B in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Invesco held 2,235,720 shares of Thermo Fisher Scientific worth $1.1B as of Q1 2026.
- Invesco bought 72,459 Thermo Fisher Scientific shares in Q1 2026, an estimated $39.3M.
- Thermo Fisher Scientific made up 0.11% of Invesco's portfolio in Q1 2026, its #155 holding.
- Invesco first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Invesco's Thermo Fisher Scientific position peaked at $1.25B in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.